NEW YORK, May 3 - Schering said today it hopes to close the sale of its 24-percent stake in Aventis' CropScience unit to Bayer between May 20 and June 5.

Bayer agreed to acquire the CropScience business from Aventis and Schering for7.25 billion, or roughly $6.63 billion, in a deal that will propel Bayer to the No. 2 spot in the agrochemicals sector.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.